IL4I1-driven AHR signature: a new avenue for cancer therapy.

Signal Transduct Target Ther

NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.

Published: March 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946875PMC
http://dx.doi.org/10.1038/s41392-021-00529-zDOI Listing

Publication Analysis

Top Keywords

il4i1-driven ahr
4
ahr signature
4
signature avenue
4
avenue cancer
4
cancer therapy
4
il4i1-driven
1
signature
1
avenue
1
cancer
1
therapy
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!